Abstract
Objective: To evaluate the effect of second-stage epidural bupivacaine on the outcome of labor. Methods: Two groups of 35 patients each were randomly allocated to receive continuous epidural bupivacaine throughout labor (group 1) or until an 8-cm dilatation of the cervix (group 2). Results: There was no significant difference between the 2 groups in the rates of instrument deliveries and in their Apgar scores. Conclusions: The administration of continuous epidural bupivacaine (0.25%) throughout labor and delivery does not seem to affect the outcome of labor.
Original language | English |
---|---|
Pages (from-to) | 167-170 |
Number of pages | 4 |
Journal | Gynecologic and Obstetric Investigation |
Volume | 42 |
Issue number | 3 |
DOIs | |
State | Published - 1 Jan 1996 |
Keywords
- Epidural bupivacaine
- Labor
- Second stage